Symrise and Probi sign joint research and development agreement

The German Symrise AG, a leading manufacturer of flavors, fragrances, cosmetics and health ingredients, and the probiotics company Probi AB based in Lund, Sweden, have signed a joint research and development agreement. In response to the growing need for turn-key product solutions with proven health benefits, both companies has announced their plans to collaborate on innovative projects such as in oral health applications.

“Both, in established markets as well as emerging markets, consumers become more and more sensitive to healthy nutrition and a balanced way of life. The highly complementary competencies and strategic innovation agendas of Probi and Symrise will allow us to support our joint customers in their development and marketing efforts, and to grow at an accelerated pace”, stated Dr. Heinz-Jürgen Bertram, CEO of Symrise AG.

Symrise has expertise in the research, development and manufacturing of food, beverages, cosmetics and pharmaceutical products and sees increasing potential in the health benefits of probiotics. Probi is a trailblazing company that is highly reputed in the research, development and manufacturing of probiotics. It sells some of the most effective gut and immune health probiotics available on the world market. Symrise AG currently holds a 14.97% minority share of Probi and may increase this stake in the future. The company is listed on the NASDAQ OMX Nordic exchange in Stockholm.

www.symrise.com